The influence of gender-specific factors influencing severe anxiety in psychotic major depression: role of thyroid hormones and depression severity

Asadikaram G, Khaleghi E, Sayadi A, Foulady S, Ghasemi MS, Abolhassani M, Nematollahi MH (2019) Assessment of hormonal alterations in major depressive disorder: a clinical study. Psych J 8(4):423–430. https://doi.org/10.1002/pchj.290

Article  PubMed  Google Scholar 

Asvold BO, Vatten LJ, Midthjell K, Bjoro T (2012) Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT study in Norway. J Clin Endocrinol Metab 97(1):93–99. https://doi.org/10.1210/jc.2011-1724

Article  CAS  PubMed  Google Scholar 

Benard V, Pignon B, Geoffroy PA, Benradia I, Roelandt JL, Rolland B, Amad A (2020) Depression with and without a history of psychotic symptoms in the general population: sociodemographic and clinical characteristics. J Affect Disord 273:247–251. https://doi.org/10.1016/j.jad.2020.04.048

Article  PubMed  Google Scholar 

Buras A, Battle L, Landers E, Nguyen T, Vasudevan N (2014) Thyroid hormones regulate anxiety in the male mouse. Horm Behav 65(2):88–96. https://doi.org/10.1016/j.yhbeh.2013.11.008

Article  CAS  PubMed  Google Scholar 

Chen H, Wang X, Huang Y, Li G, Liu Z, Li Y, Geng H (2019) Prevalence, risk factors and multi-group latent class analysis of lifetime anxiety disorders comorbid depressive symptoms. J Affect Disord 243:360–365. https://doi.org/10.1016/j.jad.2018.09.053

Article  PubMed  Google Scholar 

Davies MR, Glen K, Mundy J, Ter Kuile AR, Adey BN, Armour C, Eley TC (2023) Factors associated with anxiety disorder comorbidity. J Affect Disord 323:280–291. https://doi.org/10.1016/j.jad.2022.11.051

Article  PubMed  PubMed Central  Google Scholar 

Deligiannidis KM, Rothschild AJ, Barton BA, Kroll-Desrosiers AR, Meyers BS, Flint AJ, Group S-PS (2013) A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. J Clin Psychiatry 74(10):1003–1009. https://doi.org/10.4088/JCP.13m08400

Article  PubMed  PubMed Central  Google Scholar 

Diefenbach GJ, Bragdon L, Goethe JW (2013) Treating anxious depression using repetitive transcranial magnetic stimulation. J Affect Disord 151(1):365–368. https://doi.org/10.1016/j.jad.2013.05.094

Article  PubMed  Google Scholar 

Dubovsky SL, Ghosh BM, Serotte JC, Cranwell V (2021) Psychotic depression: diagnosis, Differential diagnosis, and treatment. Psychother Psychosom 90(3):160–177. https://doi.org/10.1159/000511348

Article  PubMed  Google Scholar 

Feng G, Kang C, Yuan J, Zhang Y, Wei Y, Xu L, Yang J (2019) Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder. Psychoneuroendocrinology 107:119–123. https://doi.org/10.1016/j.psyneuen.2019.05.013

Article  CAS  PubMed  Google Scholar 

Fischer S, Ehlert U (2018) Hypothalamic-pituitary-thyroid (HPT) axis functioning in anxiety disorders. A systematic review. Depress Anxiety 35(1):98–110. https://doi.org/10.1002/da.22692

Article  CAS  PubMed  Google Scholar 

Gaspersz R, Lamers F, Wittenberg G, Beekman ATF, van Hemert AM, Schoevers RA, Penninx B (2017) The role of anxious distress in immune dysregulation in patients with major depressive disorder. Transl Psychiatry 7(12):1268. https://doi.org/10.1038/s41398-017-0016-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaspersz R, Nawijn L, Lamers F, Penninx B (2018) Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome. Curr Opin Psychiatry 31(1):17–25. https://doi.org/10.1097/yco.0000000000000376

Article  PubMed  Google Scholar 

Goto M, Yoshimura R, Kakihara S, Shinkai K, Yamada Y, Kaji K, Nakamura J (2006) Risperidone in the treatment of psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 30(4):701–707. https://doi.org/10.1016/j.pnpbp.2006.01.016

Article  CAS  PubMed  Google Scholar 

Grassi-Oliveira R, Brietzke E, Pezzi JC, Lopes RP, Teixeira AL, Bauer ME (2009) Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry Clin Neurosci 63(2):202–208. https://doi.org/10.1111/j.1440-1819.2008.01918.x

Article  CAS  PubMed  Google Scholar 

Gutiérrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-González N, Cervilla JA (2020) Prevalence and correlates of major depressive disorder: a systematic review. Braz J Psychiatry 42(6):657–672. https://doi.org/10.1590/1516-4446-2020-0650

Article  PubMed  PubMed Central  Google Scholar 

Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50–55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x

Article  CAS  PubMed  Google Scholar 

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23(1):56–62. https://doi.org/10.1136/jnnp.23.1.56

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF (2018) Epidemiology of adult DSM-5 major depressive disorder and its Specifiers in the United States. JAMA Psychiatry 75(4):336–346. https://doi.org/10.1001/jamapsychiatry.2017.4602

Article  PubMed  PubMed Central  Google Scholar 

Heslin M, Young AH (2018) Psychotic major depression: challenges in clinical practice and research. Br J Psychiatry 212(3):131–133. https://doi.org/10.1192/bjp.2017.43

Article  CAS  PubMed  Google Scholar 

Huang Y, Sun P, Wu Z, Guo X, Wu X, Chen J, Fang Y (2023) Comparison on the clinical features in patients with or without treatment-resistant depression: a National Survey on Symptomatology of Depression report. Psychiatry Res 319:114972. https://doi.org/10.1016/j.psychres.2022.114972

Article  PubMed  Google Scholar 

Joffe RT, Levitt AJ (2008) Basal thyrotropin and major depression: relation to clinical variables and treatment outcome. Can J Psychiatry 53(12):833–838. https://doi.org/10.1177/070674370805301209

Article  PubMed  Google Scholar 

Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276. https://doi.org/10.1093/schbul/13.2.261

Article  CAS  PubMed  Google Scholar 

Kim-Romo DN, Rascati KL, Richards KM, Ford KC, Wilson JP, Beretvas SN (2016) Medication adherence and persistence in patients with severe major depressive disorder with psychotic features: antidepressant and second-generation antipsychotic therapy Versus Antidepressant Monotherapy. J Manag Care Spec Pharm 22(5):588–596. https://doi.org/10.18553/jmcp.2016.22.5.588

Article  PubMed  Google Scholar 

Konstantakou P, Chalarakis N, Valsamakis G, Sakkas EG, Vousoura E, Gryparis A, Mastorakos G (2021) Associations of thyroid hormones Profile during normal pregnancy and Postpartum with anxiety, Depression, and Obsessive/Compulsive disorder scores in Euthyroid Women. Front Neurosci 15:663348. https://doi.org/10.3389/fnins.2021.663348

Article  PubMed  PubMed Central  Google Scholar 

Kwong ASF, Morris TT, Pearson RM, Timpson NJ, Rice F, Stergiakouli E, Tilling K (2021) Polygenic risk for depression, anxiety and neuroticism are associated with the severity and rate of change in depressive symptoms across adolescence. J Child Psychol Psychiatry 62(12):1462–1474. https://doi.org/10.1111/jcpp.13422

Article  PubMed  Google Scholar 

Leung CM, Wing YK, Kwong PK, Lo A, Shum K (1999) Validation of the chinese-cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr Scand 100(6):456–461. https://doi.org/10.1111/j.1600-0447.1999.tb10897.x

Article  CAS  PubMed  Google Scholar 

Li Z, Wang Z, Zhang C, Chen J, Su Y, Huang J, Fang Y (2017) Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: result from a prospective longitudinal study. Psychoneuroendocrinology 81:113–121. https://doi.org/10.1016/j.psyneuen.2017.03.015

Article  CAS  PubMed  Google Scholar 

Liao A, Walker R, Carmody TJ, Cooper C, Shaw MA, Grannemann BD, Trivedi MH (2019) Anxiety and anhedonia in depression: associations with neuroticism and cognitive control. J Affect Disord 245:1070–1078. https://doi.org/10.1016/j.jad.2018.11.072

Article  PubMed  Google Scholar 

Lim K, Peh OH, Yang Z, Rekhi G, Rapisarda A, See YM, Lam M (2021) Large-scale evaluation of the positive and negative syndrome scale (PANSS) symptom architecture in schizophrenia. Asian J Psychiatr 62:102732. https://doi.org/10.1016/j.ajp.2021.102732

Article  PubMed  Google Scholar 

Lin J, Wang X, Dong F, Du Y, Shen J, Ding S, Xu H (2018) Validation of the Chinese version of the Hamilton Rating Scale for Depression in adults with epilepsy. Epilepsy Behav 89:148–152. https://doi.org/10.1016/j.yebeh.2018.10.009

Article  PubMed  Google Scholar 

Liu W, Wu Z, Sun M, Zhang S, Yuan J, Zhu D, Hou K (2022) Association between fasting blood glucose and thyroid stimulating hormones and suicidal tendency and disease severity in patients with major depressive disorder. Bosn J Basic Med Sci 22(4):635–642. https://doi.org/10.17305/bjbms.2021.6754

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo G, Li Y, Yao C, Li M, Li J, Zhang X (2023) Duration of untreated illness and clinical correlates in first-episode and drug-naïve patients with major depressive disorder. Psychiatry Res 320:115056. https://doi.org/10.1016/j.psychres.2023.115056

Article  PubMed 

留言 (0)

沒有登入
gif